Patent Assignment
Reel/Frame 066294/0580
Assignment of Assignor's Interest
Recorded: 2024-01-30
Pages: 4
Assignee
SHANGHAI ARGO BIOPHARMACEUTICAL CO., LTD.
337 SHAHE ROAD, J2026 ROOM 1_203, JIANGQIAO TOWN JIADING DISTRICT SHANGHAI, 201803, CHINA
Covered Property
(1)
Composition and Method for Inhibiting Angiotensinogen (Agt) Protein Expression
Application:
18/473,829 →
Publication:
US 2024/0084304